Skip to content

Development and application of a Phosphorus Counting Table for control of blood level of phosphorus in patients with Bone Disease in hemodialysis

Characterization and application of a Phosphorus Counting Table for control of hyperphosphatemia in patients with Bone Mineral Disease

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-2vzd48
Enrollment
Unknown
Registered
2018-05-15
Start date
2012-01-09
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperphosphatemia

Interventions

The study consisted of 50 hemodialysis participants, of both sexes, which had phosphate binders suspended 30 days prior to the intervention start. The participants received food and nutrition educatio
Other
SP6.026

Sponsors

Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo
Lead Sponsor
Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo
Collaborator

Eligibility

Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: Patients with chronic kidney disease and disease–mineral and bone disorder in hemodialysis; age range greater than or equal to 18 years; literate or had literate carer; serum phosphorus levels less than or equal to 7,8mg/dL after thirty days of phosphate binder cessation; sign the written informed consent form

Exclusion criteria

Exclusion criteria: Patients in use of anti-inflammatory hormones; patients with neoplasias or active infectious diseases

Design outcomes

Primary

MeasureTime frame
Reduction in serum levels of phosphorus based on the observation of a negative variation of 5% in the measurements before and after (30 and 60 days) intervention with the Phosphorus Counting Table;Maintenance in serum levels of phosphorus by observing the measurements before and after (30 and 60 days) intervention with the Phosphorus Counting Table

Secondary

MeasureTime frame
Reduction in 5% of phosphorus intake by means of analysis of phosphorus intake during before and after intervention through 3-d food record;Maintenance of nutritional status by observing the means of body mass index greater than or equal to 18 Kg/m2 and serum levels of total protein between 6 and 8 g/dL, albumin greater than 3,8 g/dL, total lymphocyte count greater than 1200 mm3, creatinine greater than 9 mg/dL, total cholesterol between 100 and 200 mg/dL and transferrin between 250 and 450 mg/dL during the interval before and after intervention

Countries

Brazil

Contacts

Public ContactJosé Costa

Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo

jacdcost@fmrp.usp.br+55-016-36022896

Outcome results

None listed

Source: REBEC (via WHO ICTRP) · Data processed: Mar 3, 2026